SPAC · Liquidated
LAVA Medtech Acquisition Corp.
LAVA Medtech Acquisition Corp. is a blank-check company (SPAC) that raised $100M in its initial public offering on Oct 28, 2021, listing on Nasdaq Global Market. It did not complete a business combination and liquidated around May 12, 2023, returning the trust to public shareholders. Senior Partner of InnovaHealth Partners led the IPO, with MDS Capital. Reed Smith advised the SPAC and Skadden, Arps advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Oct 28, 2021
- IPO size
- $100M
- IPO exchange
- Nasdaq Global Market
- IPO underwriters
- Senior Partner of InnovaHealth Partners and MDS Capital
- SPAC counsel (IPO)
- Reed Smith
- Underwriters' counsel (IPO)
- Skadden, Arps
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Oct 28, 2021
- All filings on EDGAR CIK 1855450
Other SPAC IPOs from 2021
- Focus Impact Acquisition Corp.Oct 29, 2021 · $200M
- Pyrophyte Acquisition Corp.Oct 28, 2021 · $175M
- Roth CH Acquisition Co. (Roth CH Acquisition V)Oct 28, 2021 · $200M
- Innovative International Acquisition Corp.Oct 28, 2021 · $200M
- Opy Acquisition Corp. IOct 28, 2021 · $110M
- Deep Medicine Acquisition Corp.Oct 28, 2021 · $110M